Table 3 Baseline patient characteristics
From: A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes
| Â | Median (range) |
|---|---|
Age | 70.6 years (54.6–78.9) |
PSA | 12.4 ng/mL (4.0–52.1) |
% biopsy cores positive | 50 % (25–100) |
Gleason Score | Number of patients (percentage) |
 3 + 4 | 2 (7 %) |
 4 + 3 | 3 (11 %) |
 4 + 4 | 3 (11 %) |
 4 + 5 | 16 (59 %) |
 5 + 4 | 4 (15 %) |
T stage | Number of patients (percentage) |
 T1b | 1 (4 %) |
 T1c | 3 (11 %) |
 T2a | 1 (4 %) |
 T2b | 7 (25 %) |
 T2c | 4 (14 %) |
 T3a | 9 (32 %) |
 T3b | 3 (11 %) |